Frontlight ResearchEarly access
Trial site
Institucion Hospitalaria Hestia Palau
- 2closed trials
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Schizophrenia1 trial
- Phase
- Phase 2/31 trial
- Phase 31 trial
- Status
- Completed2 trials
- Lead sponsor
- Neurocrine Biosciences Inc.1 trial
- Otsuka Pharmaceutical Development & Commercialization, Inc.1 trial
Closed trials
Site data: EU CTIS (euclinicaltrials.eu)Updated 15 Nov 2026